Mankind Pharma has received a Goods and Services Tax (GST) order from the Patna authority relating to discrepancies in GST returns. The order, received on December 10, 2025, pertains to financial years 2018-19 to 2022-23, with a levied penalty of INR 15,31,70,825. Mankind Pharma intends to appeal the order and believes it has sufficient grounds to do so.
Details of the GST Order
Mankind Pharma has been issued an order by the Office of the Principal Commissioner, Central GST & Central Excise, Patna, on December 10, 2025. This order was issued by the Joint Commissioner (“Department”).
Financial Impact and Company Response
The order relates to alleged discrepancies in the company’s GST returns, specifically disallowance of Input Tax Credit (ITC) on account of reconciliation differences. The order spans financial years 2018-19 to 2022-23 and levies a penalty of INR 15,31,70,825.
Mankind Pharma intends to file an appeal against this order with the appellate authority. Based on its assessment, the company believes that it has adequate factual and legal grounds to challenge the order and does not anticipate any material adverse impact on its financials, operations, or other activities.
Next Steps
Mankind Pharma will take appropriate actions, including filing an appeal. The company maintains that there is no material impact expected on its financials, operations, or other activities due to this order.
Source: BSE
